BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 17504144)

  • 1. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
    Musa MA; Khan MO; Cooperwood JS
    Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of SERMs for treatment in postmenopausal women.
    Pinkerton JV; Thomas S
    J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.
    Gajdos C; Jordan VC
    Clin Breast Cancer; 2002 Jan; 2(4):272-81. PubMed ID: 11899358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
    Dhingra K
    Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
    Jirecek S; Pavo I; Huber JC
    Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs).
    Lewis-Wambi JS; Jordan VC
    Breast Dis; 2005-2006; 24():93-105. PubMed ID: 16917142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
    Thiebaud D; Secrest RJ
    Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacological review of selective oestrogen receptor modulators.
    Goldstein SR; Siddhanti S; Ciaccia AV; Plouffe L
    Hum Reprod Update; 2000; 6(3):212-24. PubMed ID: 10874566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects.
    Muchmore DB
    Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
    Park WC; Jordan VC
    Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
    Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS
    J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting in the estrogen receptor hormonal pathway.
    Katzenellenbogen BS; Frasor J
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):28-38. PubMed ID: 15052541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
    Pinkerton JV; Goldstein SR
    Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective estrogen receptor modulators.
    Haskell SG
    South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens--tamoxifen, SERMs and beyond.
    Dhingra K
    Invest New Drugs; 1999; 17(3):285-311. PubMed ID: 10665480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.